NEWSROOM
Discover all the actions carried out by Jeito and all the partnerships that we set up day after day for the well-being of patients and medical progress.
In the headlines
Jeito Capital appoints Pascal Touchon as Operating Partner
Pascal Touchon will reinforce Jeito's expertise by bringing over 35 years of global experience in drug development, commercial activities, operational and strategic leadership at major international pharmaceutical groups and biotech companies. He will support the...
Download our White Paper
We are pleased to share with you our White Paper, which offers a deep dive into the evolving biopharma landscape and highlights the key trends shaping its future.
Find all our press releases
Jeito Capital co-leads $76 million Series A financing for CDR-Life its 10th investment since its launch
Paris, France, April 13, 2022 - Jeito Capital ("Jeito"), a leading independent Private Equity firm...
Jeito Capital co-leads EUR 80 million euro Series B financing in European oncology company, Precirix
Paris, France, March 2022, 16th – Jeito Capital (“Jeito”), a leading independent private equity...
Jeito Capital co-leads $65 million Series A financing in EyeBio
Paris, France, 22 February 2022 – Jeito Capital (“Jeito”), a leading independent private equity...
JEITO CAPITAL becomes key investor in NMD Pharma as part of a €35 Million new financing
Jeito Capital selected European clinical stage biotech NMD Pharma, based in Denmark, as its 7th...
Jeito Capital co-leads $156million oversubscribed Series B financing in Quell Therapeutics
Quell Therapeutics is the world leader in developing engineered T-regulatory (Tregs) cell...
Jeito Capital portfolio company SparingVision announces strategic collaboration with Intellia Therapeutics
Partnership will allow SparingVision to develop novel genomic medicines for the treatment of...
Face to face
Meet Jeito
12-15
January
All day long
JPM Healthcare Conference 2026
Jeito will be present at the 44th JPM Healthcare Conference 2026, renowned as the largest and most influential healthcare investment symposium, attracting global industry leaders, Biotech companies, and members of the investment community, in San Francisco.